The Clinical trial Information Releases of New Drug companies and their Abnormal Returns in Taiwan Stock Market
碩士 === 國立交通大學 === 管理學院管理科學學程 === 103 === Recently, the stock prices for Biotech patented new drug companies have a huge surge in Taiwan, because all of these companies have researched to different phases of clinical trial for many years. These Biotech drug companies are not only sold in the market o...
Main Authors: | Lin,Ching-Ling, 林靜伶 |
---|---|
Other Authors: | Chu, Po-Young |
Format: | Others |
Language: | zh-TW |
Published: |
2015
|
Online Access: | http://ndltd.ncl.edu.tw/handle/c3ecdd |
Similar Items
-
The Influences of the American Presidential Election Event on the Abnormal Returns of Taiwan's Stock market
by: CHANG,SHU-CHING, et al.
Published: (2017) -
The Abnormal Returns of IPOs in the Taiwan''s Stock Market
by: Chien, Heng-Jung, et al.
Published: (1998) -
An Examination of Abnormal Stock Returns and R&D Expenditure Information
by: MING-LING HSU, et al.
Published: (2019) -
A Study of the Abnormal Return on Taiwan’s Emerging Company transferring to the Listing Stock Market
by: LIAO,CHAN-CHEN, et al.
Published: (2016) -
The Effects of Typhoon on the Abnormal Returns in the Taiwan Stock Market
by: CHEN,MEI-HUI, et al.
Published: (2019)